- The scientific and clinical communities have a better understanding of and access to new and innovative products for the treatment of antimicrobial resistant bacteria and fungi, as well as for further clinical investigation. - Candidate therapies are available to treat patients for antimicrobial resistant bacteria and fungi, increasing therapeutic options for clinical deployment in the fight against Antimicrobial Resistance (AMR).
The conditions for qualifying. An eligibility check tests your details against each one.
At least 3 independent partners
Does your company qualify?
Give a few facts about your company and project, and see for each condition whether you meet it.
Eligibility checkGrant from URBAN PROSUMERS (EU-funded project) across the EU. Total budget €180,000. Applications until 30 September 2026.
- Complete Indicator Framework: A validated indicator framework of short-term actions, outcomes and long-term impacts, for both the ECS programme and the Chips for Europe Initiative, integr…
This topic is the first phase of a two-phase competitive structure supported by Horizon Europe, implemented via a Coordination and Support Action (CSA) in close collaboration with the Europ…
A check is an indication from the published conditions and the facts you give. Only the competent authority decides whether you are eligible.